Skip to main content
Caplight Logo









Pangea Biomed

Pangea Biomed

Private
Tel AvivHealthcare & Life Scienceshttps://pangeabiomed.com/

Last Round

Seed

Dec 15, 2022

Total Funding Raised

$19M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Pangea Biomed is a biotechnology company that has developed ENLIGHT, a computational platform using RNA analysis and machine learning to predict cancer therapy responses and personalize cancer care.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Drug Discovery, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

precision oncologycomputational biologybiomarker developmentclinical trial optimizationdrug discoverydigital pathologytranscriptomicsai drug discoverypredictive analyticsmolecular diagnosticscancer researchprecision medicineai in healthcarebiotech aimedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pangea Biomed Comparables

Compare Pangea Biomed with similar companies based on industry and business-model similarity.

Pangea Biomed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genialis
81%
Blank Bio
78%
Strata Oncology
76%

Pangea Biomed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 15, 2022
SeedApr 8, 2022

Key People

Founding team and executive leadership

Tuvik Beker

Chief Executive Officer

Executive Team

Emmanuel Elalouf

Chief Operating Officer

Executive Team

Pangea Biomed Investors

Notable investors and investment history

Pangea Biomed investors
InvestorRounds
NFXSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 559% MoM.

  • Jun 18, 2026

    Monthly visitors grew 2738% MoM, from 8 to 227.

Pangea Biomed Filings

Explore SEC and related filing metadata, where available.

Pangea Biomed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pangea Biomed's valuation, stock price, and market status.

Is Pangea Biomed a public or private company?

Pangea Biomed is a private company.

What is the current stock price of Pangea Biomed?

Pangea Biomed is a private company with no public stock price. No recent secondary market data is available.

How much is Pangea Biomed worth (valuation)?

Valuation information for Pangea Biomed is not publicly available.

Can I buy Pangea Biomed stock?

Pangea Biomed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pangea Biomed's last funding round?

Pangea Biomed's most recent funding round was Seed on December 15, 2022.

Who are the main investors in Pangea Biomed?

Key investors in Pangea Biomed include NFX.

Will Pangea Biomed IPO soon?

No public IPO plans have been announced for Pangea Biomed.

How can I track Pangea Biomed secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pangea Biomed's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range14
Year Founded2018
Last FundingDec 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?